Technical Analysis for HAE - Haemonetics Corporation

Grade Last Price % Change Price Change
grade C 127.14 1.66% 2.08
HAE closed up 1.66 percent on Thursday, October 17, 2019, on 63 percent of normal volume.

Earnings due: Nov 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical HAE trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Fell Below 20 DMA Bearish 1.66%
Bollinger Band Squeeze Range Contraction 1.66%
Crossed Above 20 DMA Bullish 0.49%
Bollinger Band Squeeze Range Contraction 0.49%
Inside Day Range Contraction 0.49%
50 DMA Resistance Bearish 0.86%
Fell Below 20 DMA Bearish 0.86%
Bollinger Band Squeeze Range Contraction 0.86%

Older signals for HAE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Haemonetics Corporation engages in the design, development, manufacture, and marketing of automated blood component collection devices and surgical blood salvage devices in the United States and internationally. It provides various plasma products, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and blood center products comprising multicomponent collection system brand apheresis equipment to collect specific blood components integrated from the donor, automated cell processor brand solution to automate the washing and freezing of red cell components in the lab, and filtration products. The company also offers various hospital products, such as TEG thrombelastograph hemostasis analyzer system that measures a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system for cardiovascular surgery procedures; OrthoPAT surgical blood salvage system for orthopedic procedures; cardioPAT system to open heart surgeries; and IMPACT Online Web-based software platform that monitors and measures improvements in a hospital's blood management practices, provides hospitals with a view of their blood management metrics, and helps monitor transfusion rates. In addition, it offers SafeTrace Tx and BloodTrack suite of solutions, as well as El Dorado Donor donation and blood unit management systems. The company markets and sells its products to commercial plasma collectors, blood collection groups and independent blood centers, hospitals and hospital service providers, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.
Medicine Information Technology Medical Specialties Supply Chain Blood Transfusion Medicine Hematology Blood Clots Blood Transfusion Filtration Products Blood Plasma Hemostasis Plasma Products Web Based Software Platform
Is HAE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 140.36
52 Week Low 80.23
Average Volume 326,668
200-Day Moving Average 106.9995
50-Day Moving Average 128.9092
20-Day Moving Average 125.828
10-Day Moving Average 125.556
Average True Range 3.1421
ADX 12.05
+DI 27.764
-DI 23.5464
Chandelier Exit (Long, 3 ATRs ) 123.2987
Chandelier Exit (Short, 3 ATRs ) 130.8063
Upper Bollinger Band 129.3445
Lower Bollinger Band 122.3115
Percent B (%b) 0.69
BandWidth 5.589376
MACD Line -0.3308
MACD Signal Line -0.6304
MACD Histogram 0.2996
Fundamentals Value
Market Cap 6.69 Billion
Num Shares 52.6 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 1589.25
Price-to-Sales 2.78
Price-to-Book 3.19
PEG Ratio 3.50
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 130.59
Resistance 3 (R3) 130.49 129.23 130.02
Resistance 2 (R2) 129.23 128.35 129.29 129.82
Resistance 1 (R1) 128.19 127.81 128.71 128.29 129.63
Pivot Point 126.93 126.93 127.20 126.99 126.93
Support 1 (S1) 125.89 126.05 126.41 125.99 124.65
Support 2 (S2) 124.63 125.51 124.69 124.46
Support 3 (S3) 123.59 124.63 124.27
Support 4 (S4) 123.69